Subcutaneous formulations of anti-CD38 antibodies and their uses
US11566079B2 · kind B2 · utility
8Cited by
23References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2020 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Dec 18, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.